Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Takeda Pharmaceutical Total Change in Assets/Liabilities 2010-2024 | TAK

Takeda Pharmaceutical annual/quarterly total change in assets/liabilities history and growth rate from 2010 to 2024. Total change in assets/liabilities can be defined as the sum of all line items in the Asset/Liability section of the Cash Flows Statement
  • Takeda Pharmaceutical total change in assets/liabilities for the quarter ending December 31, 2024 was $-1.216B, a 23.8% decline year-over-year.
  • Takeda Pharmaceutical total change in assets/liabilities for the twelve months ending December 31, 2024 was $-6.210B, a 29.11% increase year-over-year.
  • Takeda Pharmaceutical annual total change in assets/liabilities for 2024 was $-1.819B, a 115.49% increase from 2023.
  • Takeda Pharmaceutical annual total change in assets/liabilities for 2023 was $-0.844B, a 196.16% decline from 2022.
  • Takeda Pharmaceutical annual total change in assets/liabilities for 2022 was $0.878B, a 66.15% decline from 2021.
  
Takeda Pharmaceutical Annual Total Change in Assets/Liabilities
(Millions of US $)
2024 $-1,819
2023 $-844
2022 $878
2021 $2,592
2020 $871
2019 $684
2018 $121
2017 $513
2016 $-2,034
2015 $1,659
2014 $-125
2013 $149
2012 $822
2011 $-110
2010 $152
2009 $-377
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $45.151B $30.087B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $88.594B 33.24
Zoetis (ZTS) United States $72.088B 26.90
Daiichi Sankyo, - (DSNKY) Japan $45.227B 23.01
Sandoz Group AG (SDZNY) Switzerland $19.811B 0.00
Summit Therapeutics (SMMT) United States $18.760B 0.00
Merck (MKKGY) Germany $18.016B 14.91
United Therapeutics (UTHR) United States $14.019B 12.40
Shionogi (SGIOY) Japan $13.305B 13.33
Neurocrine Biosciences (NBIX) United States $11.918B 40.82
IPSEN (IPSEY) France $9.397B 0.00
Orion OYJ (ORINY) Finland $8.215B 22.22
Corcept Therapeutics (CORT) United States $7.650B 62.19
Stevanato Group S.p.A (STVN) Italy $7.165B 43.81
Madrigal Pharmaceuticals (MDGL) United States $6.678B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.337B 0.00
Grifols, S.A (GRFS) Spain $5.315B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Soleno Therapeutics (SLNO) United States $3.865B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.120B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.907B 10.18
Hypermarcas (HYPMY) Brazil $2.591B 17.04
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.356B 12.88
BioCryst Pharmaceuticals (BCRX) United States $2.164B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.111B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.886B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.757B 0.00
Guardian Pharmacy Services (GRDN) United States $1.624B 0.00
Indivior (INDV) United States $1.564B 6.63
Evotec AG (EVO) Germany $1.481B 0.00
Dyne Therapeutics (DYN) United States $1.428B 0.00
ARS Pharmaceuticals (SPRY) United States $1.305B 166.12
Ocular Therapeutix (OCUL) United States $1.177B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.110B 21.95
Harrow (HROW) United States $0.978B 0.00
Collegium Pharmaceutical (COLL) United States $0.950B 5.12
Enliven Therapeutics (ELVN) United States $0.933B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.927B 0.00
Ardelyx (ARDX) United States $0.845B 0.00
Cronos Group (CRON) Canada $0.790B 0.00
Xeris Biopharma Holdings (XERS) United States $0.774B 0.00
AleAnna (ANNA) United States $0.712B 0.00
Akebia Therapeutics (AKBA) United States $0.638B 0.00
Xencor (XNCR) United States $0.624B 0.00
KalVista Pharmaceuticals (KALV) United States $0.606B 0.00
USANA Health Sciences (USNA) United States $0.559B 12.15
Bioventus (BVS) United States $0.552B 14.04
Regulus Therapeutics (RGLS) United States $0.545B 0.00
Relay Therapeutics (RLAY) United States $0.533B 0.00
Savara (SVRA) United States $0.522B 0.00
CytoDyn (CYDY) United States $0.476B 0.00
Elite Pharmaceuticals (ELTP) United States $0.465B 0.00
Altimmune (ALT) United States $0.463B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.440B 0.00
Siga Technologies (SIGA) United States $0.424B 8.87
Zevra Therapeutics (ZVRA) United States $0.424B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.410B 0.00
Tourmaline Bio (TRML) United States $0.405B 0.00
Verve Therapeutics (VERV) United States $0.388B 0.00
Organogenesis (ORGO) United States $0.379B 0.00
Oruka Therapeutics (ORKA) United States $0.365B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.333B 8.99
Heron Therapeutics (HRTX) United States $0.313B 0.00
Aquestive Therapeutics (AQST) United States $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.265B 24.48
ProKidney (PROK) United States $0.220B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Avita Medical (RCEL) United States $0.192B 0.00
Liminatus Pharma (LIMN) $0.185B 0.00
Wellgistics Health (WGRX) United States $0.184B 0.00
OmniAb (OABI) United States $0.175B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Inhibikase Therapeutics (IKT) United States $0.163B 0.00
Esperion Therapeutics (ESPR) United States $0.158B 0.00
Journey Medical (DERM) United States $0.158B 0.00
Nanobiotix S.A (NBTX) France $0.157B 0.00
4D Molecular Therapeutics (FDMT) United States $0.154B 0.00
Korro Bio (KRRO) United States $0.150B 0.00
Aclaris Therapeutics (ACRS) United States $0.135B 0.00
Larimar Therapeutics (LRMR) United States $0.133B 0.00
Nektar Therapeutics (NKTR) United States $0.133B 0.00
Aldeyra Therapeutics (ALDX) United States $0.132B 0.00
Profound Medical (PROF) Canada $0.129B 0.00
Protara Therapeutics (TARA) United States $0.126B 0.00
Lyell Immunopharma (LYEL) United States $0.125B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.123B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.119B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.118B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
VAXART, INC (VXRT) United States $0.092B 0.00
Cassava Sciences (SAVA) United States $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Lexeo Therapeutics (LXEO) United States $0.087B 0.00
Achieve Life Sciences (ACHV) Canada $0.086B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
Fractyl Health (GUTS) United States $0.084B 0.00
Champions Oncology (CSBR) United States $0.083B 13.64
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.079B 58.56
Inotiv (NOTV) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Context Therapeutics (CNTX) United States $0.070B 0.00
Unicycive Therapeutics (UNCY) United States $0.068B 0.00
Nutriband (NTRB) United States $0.065B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Karyopharm Therapeutics (KPTI) United States $0.053B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
PMV Pharmaceuticals (PMVP) United States $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.043B 0.00
Prelude Therapeutics (PRLD) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Surrozen (SRZN) United States $0.026B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Mannatech (MTEX) United States $0.023B 9.00
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
DURECT (DRRX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.58
Plus Therapeutics (PSTV) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00